Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide for Prevention of Severe Postpartum Hypertension
NCT02450773Phase 2Withdrawn
- Sponsor
- Indiana University
- Start
- Aug 2015
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of furosemide in hypertension (HTN), sponsored by Indiana University. Planned start Aug 2015; status: withdrawn.
02
Drugs
furosemide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02450773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02450773.